14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Fri, 3 May 2024

SPHS Predictions History

4 years ago
JS predicted that SPHS for 2020-02-10 is going $0.732 (1.69%)

4 years ago
Alan predicted that SPHS for 2020-02-10 is going $0.80 (5.96%)

4 years ago
Alan predicted that SPHS for 2020-01-15 is going $0.700 (12.90%)

4 years ago
NameNotImportant predicted that SPHS for 2019-05-06 is going $0.87 (-1.16%)

5 years ago
JS predicted that SPHS for 2018-05-17 is going $3.32 (-1.19%)

6 years ago
Warren.W.Kessler.24018 predicted that SPHS for 2018-04-30 is going $2.46 (0.82%)

Rank:

6 years ago
JS predicted that SPHS for 2017-08-14 is going $1.84 (-1.08%)

7 years ago
jeral.ceela.5055 predicted that SPHS for 2017-03-31 is going $2.72 (-4.56%)

Rank:

7 years ago
JS predicted that SPHS for 2017-02-17 is going $2.78 (0.72%)

7 years ago
JS predicted that SPHS for 2017-01-18 is going $2.88 (-10.84%)

Click to get the best stock tips daily for free!

About Sophiris Bio

Sophiris Bio Sophiris Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of products for the treatment of urological diseases. The company’s primary product candidate is PRX302, which is in Phase III clinical trial for treatment of lower urinary tract symptoms of benign prostatic hyperplasia (BPH), as well as for the treatment of localized low to intermediate risk prostate cancer. It has a strategic relationship with Kissei Pha... SPHS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT